Bank Of Montreal Biotechnology

Bank Of Montreal

$202 Billion
Q4 2024

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade	Trade History
ACAD Acadia Pharmaceuticals Inc	$3.13B	$211,000 0.0% of portfolio	11,522	Q4 2024 New
ENTA Enanta Pharmaceuticals Inc	$163M	$182,000 0.0% of portfolio	31,748	Q4 2024 New
AVTE Aerovate Therapeutics, Inc.	$59.2M	$156,000 0.0% of portfolio	59,097	Q4 2024 Added 86.76%
ABCL Ab Cellera Biologics Inc.	$833M	$150,000 0.0% of portfolio	51,447	Q4 2024 Reduced 11.32%
REPL Replimune Group, Inc.	$623M	$149,000 0.0% of portfolio	12,326	Q4 2024 Reduced 11.25%
RPTX Repare Therapeutics Inc.	$50.3M	$137,000 0.0% of portfolio	105,241	Q4 2024 Reduced 0.01%
FDMT 4 D Molecular Therapeutics, Inc.	$145M	$122,000 0.0% of portfolio	21,982	Q4 2024 Reduced 58.85%
GERN Geron Corp	$657M	$117,000 0.0% of portfolio	33,147	Q4 2024 Added 38.86%
NVAX Novavax Inc	$552M	$115,000 0.0% of portfolio	14,315	Q4 2024 Reduced 99.42%
BCRX Biocryst Pharmaceuticals Inc	$1.57B	$103,000 0.0% of portfolio	13,785	Q4 2024 Added 0.45%
CCCC C4 Therapeutics, Inc.	$127M	$88,000 0.0% of portfolio	24,450	Q4 2024 Reduced 54.82%
DMAC Dia Medica Therapeutics Inc.	$166M	$82,000 0.0% of portfolio	15,560	Q4 2024 New
PRQR Pro Qr Therapeutics N.V.	$173M	$81,000 0.0% of portfolio	30,000	Q4 2023 New
ADPT Adaptive Biotechnologies Corp	$1.17B	$78,000 0.0% of portfolio	13,022	Q4 2024 Reduced 0.01%
RXRX Recursion Pharmaceuticals, Inc.	$1.38B	$78,000 0.0% of portfolio	11,585	Q4 2024 New
CRBU Caribou Biosciences, Inc.	$70.6M	$74,000 0.0% of portfolio	46,728	Q4 2024 Added 0.77%
VIR Vir Biotechnology, Inc.	$1.08B	$73,000 0.0% of portfolio	10,036	Q4 2024 Reduced 13.3%
HLVX Hille Vax, Inc.	$60.2M	$72,000 0.0% of portfolio	35,763	Q4 2024 Added 47.15%
LXRX Lexicon Pharmaceuticals, Inc.	$126M	$51,000 0.0% of portfolio	70,000	Q4 2024 Reduced -0.0%
NKTR Nektar Therapeutics	$150M	$50,000 0.0% of portfolio	54,500	Q4 2024 Reduced -0.0%
VTYX Ventyx Biosciences, Inc.	$82M	$47,000 0.0% of portfolio	21,781	Q4 2024 Added 23.04%
BCAB Bio Atla, Inc.	$11.3M	$43,000 0.0% of portfolio	73,484	Q4 2024 Reduced 87.67%
ONCY Oncolytics Biotech Inc	$41.1M	$36,000 0.0% of portfolio	39,231	Q4 2024 Added 3.45%
CHRS Coherus Bio Sciences, Inc.	$83.9M	$34,000 0.0% of portfolio	24,690	Q4 2024 New
IBRX Immunity Bio, Inc.	$1.14B	$32,000 0.0% of portfolio	12,722	Q4 2024 Reduced 95.14%
LEXX Lexaria Bioscience Corp.	$9.4M	$29,000 0.0% of portfolio	14,000	Q3 2024 New
IPA Immuno Precise Antibodies Ltd.	$8.44M	$14,000 0.0% of portfolio	35,307	Q4 2024 Reduced 38.92%
SGMO Sangamo Therapeutics, Inc	$150M	$12,000 0.0% of portfolio	12,000	Q4 2024 Reduced 0.47%
LYRA Lyra Therapeutics, Inc.	$6.68M	$11,000 0.0% of portfolio	54,130	Q4 2024 Reduced 54.66%
VXRT Vaxart, Inc.	$62M	$9,000 0.0% of portfolio	15,125	Q1 2024 New
SBTX Silverback Therapeutics, Inc.	$0	$0 0.0% of portfolio	340,591	Q4 2024 New

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of Montreal , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of Montreal with notifications on news.